Focal hepatic tuberculosis in a patient with acquired immunodeficiency syndrome. 1991

M A Kielhofner, and R J Hamill
Department of Medicine, Baylor College of Medicine, Houston, TX.

Patients infected with HIV are known to have unusual manifestations of a variety of infections. We have described the third reported case of a patient with AIDS having an apparent pyogenic liver abscess subsequently diagnosed as focal hepatic tuberculosis. This case emphasizes the need for aggressive diagnostic procedures for evaluation of focal liver abnormalities in these patients.

UI MeSH Term Description Entries
D008297 Male Males
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014386 Tuberculosis, Hepatic Infection of the LIVER with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS. It is characterized by localized small tuberculous miliary lesions or tumor-like mass (TUBERCULOMA), and abnormalities in liver function tests. Hepatic Tuberculoses,Hepatic Tuberculosis,Tuberculoses, Hepatic

Related Publications

M A Kielhofner, and R J Hamill
January 1985, The Journal of infection,
M A Kielhofner, and R J Hamill
October 2016, Archivos argentinos de pediatria,
M A Kielhofner, and R J Hamill
January 2000, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
M A Kielhofner, and R J Hamill
August 1992, The Pediatric infectious disease journal,
M A Kielhofner, and R J Hamill
February 1997, Pediatric radiology,
M A Kielhofner, and R J Hamill
November 1990, Journal of the American Academy of Dermatology,
M A Kielhofner, and R J Hamill
July 1987, The American journal of the medical sciences,
M A Kielhofner, and R J Hamill
June 1989, Archives of internal medicine,
Copied contents to your clipboard!